Major drug dealers compete to lay out this field: China Resources, State Control, Kyushua Tong...

On September 24, the Chinese government procurement network issued the "Public Tender Announcement for Drug Supply Chain Extension Services for Civil Aviation Shanghai Hospitals".
announcement, the project is mainly aimed at improving the hospital drug logistics, deployment, information management level, improve patient satisfaction, service providers tender.
project is not intended for SME procurement.
tender documents will be available from September 25 to September 30, 2020 at RMB500 per copy (after sale);
This is a topic we haven't talked about for a long time, and today we have this opportunity to talk about drug supply chain extension services, which is often called pharmaceutical SPD supply chain management, also known as pharmaceutical intensive operation services.
major pharmaceutical companies, are in the layout of pharmaceutical SPD is well known, pharmaceutical SPD was born after the pharmacy trusteeship.
in 2018, the National Health and Wellness Commission officially issued a call to stop pharmacy trusteeship, pharmaceutical SPD has become a model that many pharmaceutical commercial companies are exploring.
SPD is an acronym for the English words supply (supply), processing (management) and distribution (distribution), and is a supply chain management model that is more respected by modern medical institutions.
2020 half-yearly reports of major listed pharmaceutical companies found that more or less of them have pharmaceutical SPD-related content.
China Resources Pharmaceuticals: In the 2020 Semi-Annual Report released recently, the "Prospects and Future Strategy" section mentions that the company will strengthen the advantageous areas, optimize the business structure, build smart pharmaceutical supply chain service providers, and realize the transformation from traditional commercial distribution business to intelligent, specialized integrated service providers.
for medical terminals, the company will take the initiative to provide product services, through information technology, specialized services, to assist in the design of supply chain management and hospital logistics intelligent integration solutions.
Pharmaceutical Holdings: In the recently released 2020 semi-annual report mentioned that in the past two years, drug belt purchase, national health insurance negotiations and other regulatory policies have had a profound impact on the drug distribution industry.
The Group actively responds to supplier strategies and business structure adjustments resulting from industry changes, digs deep into unique network and service advantages, continuously takes volume purchase as its core, promotes the development of supply chain value-added business with higher profitability, and accelerates the Group's transformation and upgrading to service providers with comprehensive promotion capabilities.
Shanghai Pharmaceuticals: In its 2020 semi-annual report released recently, the company adheres to innovative drug distribution methods, continuously serves the reform of public medical institutions, and continuously improves service efficiency and experience through leading supply chain management, information technology and logistics technologies to meet the needs of the public and medical institutions.
company in the hospital supply chain extension services, third-party logistics services, drug delivery services, imported drugs one-stop service, vaccine services, pharmacy information management and clinical support services and other innovative business models in the domestic leading level.
KyusjuTong: In the recently released 2020 semi-annual report, the company has formed three major product lines for pharmaceutical logistics enterprises, such as "logistics planning and integration of integrated solutions", "supply chain integration and integrated solutions" for pharmaceutical enterprises, and "hospital supply chain coordination solutions and health information management systems" for hospitals and regional medical management institutions.
, medical supplies procurement, inventory and management software and information systems designed and developed for medical institutions have significant application value in the logistics management of medical supplies and medicines in medical institutions.
pharmaceutical SPD equal to pharmacy custody? Pharmaceutical SPD is not the same as pharmacy hosting, whether conceptually, operationally, or legally.
as also noted above, pharmaceutical SPD supply chain management refers to a supply chain management service that centralizes the supply, inventory, processing and distribution of medical materials in hospitals, replaces the traditional material management mode of hospitals, improves the efficiency of hospital medical materials management, enhances the modernization level of hospital operations, and reduces the cost of medical materials management.
And pharmacy trusteeship is the medical institutions should be their own performance of the pharmacy management work in the form of a contract entrusted to others to perform, for this purpose signed a pharmacy trusteeship agreement, the trustee enterprise in accordance with the contract, to assume the pharmacy management.
present, most of the second-class A-level hospitals have a high degree of information construction of foreign hospitals, but in-hospital logistics and in-hospital asset management information construction is very lacking, even manual extensive management.
, with the deepening of medical and health services reform, hospitals did not pay attention to in-hospital logistics began to become the focus of the reform of major hospitals.
Comparing pharmaceutical SPD and pharmacy custody, we can find that there are great differences between the two: (drawing: Ethernet Technology) Jiangsu Province Pharmaceutical Co., Ltd. retail procurement manager Jia Xiaoqing told SaiBaiLan, pharmaceutical SPD is different from hospital custody pharmacy, pharmaceutical SPD is equivalent to an extension of logistics, is to solve the medical, circulation, manufacturers and patients links, reduce medical operating costs, is an integrated mode of connectivity.
on whether there was a monopoly on distribution of pharmaceutical SPDs, he said that since the partners were bidding, the process was compliant.
the current Anti-monopoly Law, operators can implement centralization in accordance with the law through fair competition and voluntary union, expand the scale of operation and improve market competitiveness.
addition, the Measures for the Administration of Government Purchase of Services also make it clear that public welfare second-class institutions can be used as the main body of government purchase of services.
this gives public hospitals as public welfare category II the legitimacy to purchase in-house supply chain management services.
therefore, the existence of pharmaceutical SPDs is legal and compliant.
pharmaceutical SPD do it well? Behind the scenes of pharmacy trusteeship, many pharmacies are turning their attention to pharmaceutical SPD supply chain management.
is this field very good to do, very profitable, or has a great market prospect? On this issue, Jia Xiaoqing said to Cypress Blue, pharmaceutical SPD is a heavy investment project, moving millions of inputs, for circulation enterprises are large projects, the current participation in bidding for this project is generally state-owned enterprises, provincial state-owned enterprises, large private circulation and some large-scale production enterprises, huge investment is not the general circulation enterprises can afford.
He revealed that the current pharmaceutical business for circulation suppliers extension projects are still relatively many, such as infusion center projects, pharmaceutical services, etc. , although in the exploration period, but in fact very much burning money.
Pharmaceutical SPD focus on information technology, equipment and manpower, to open the medical purchase and sale of deposit, invoices, financial and other systems docking, equipment purchase, maintenance and related personnel cost investment is very large.
's 2020 Semi-Annual Report on BaiyunShan found that eight of the "changes in major projects under construction" were hospital service extension projects with a total budget investment of RMB850 million.
(data source: listed company report) from this series of data, but also fully confirmed that pharmaceutical SPD is a very large investment, but it is the pharmaceutical business has to work hard for the direction of development.
jia Xiaoqing told Saibai Blue, the ban on pharmacy trusteeship is currently from the state to local documents have been very clear, although there are still some cooperation with hospital enterprises are continuing to implement, after all, the policy landing from the contract period there is still a time difference, after the contract period can be completely banned, but also depends on the real implementation of local and hospital strength.
sure, the nearly 20-year-old hosting model has indeed come to an end in history, and pharmaceutical companies must keep up with the industry.
after all, in today's medical reform situation, the era of survival by distribution alone is over.
.